171 related articles for article (PubMed ID: 25117073)
1. Expression of HSPA2 in human hepatocellular carcinoma and its clinical significance.
Fu Y; Zhao H; Li XS; Kang HR; Ma JX; Yao FF; Du N
Tumour Biol; 2014 Nov; 35(11):11283-7. PubMed ID: 25117073
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of HSPA2 is correlated with poor prognosis in esophageal squamous cell carcinoma.
Zhang H; Chen W; Duan CJ; Zhang CF
World J Surg Oncol; 2013 Jun; 11():141. PubMed ID: 23777267
[TBL] [Abstract][Full Text] [Related]
3. Expression and clinical significance of HSPA2 in pancreatic ductal adenocarcinoma.
Zhang H; Gao H; Liu C; Kong Y; Wang C; Zhang H
Diagn Pathol; 2015 Mar; 10():13. PubMed ID: 25890028
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of IQGAP1/2 in Hepatocellular carcinoma and its relationship with clinical outcomes.
Xia FD; Wang ZL; Chen HX; Huang Y; Li JD; Wang ZM; Li XY
Asian Pac J Cancer Prev; 2014; 15(12):4951-6. PubMed ID: 24998570
[TBL] [Abstract][Full Text] [Related]
5. High expression of thymosin beta 10 predicts poor prognosis for hepatocellular carcinoma after hepatectomy.
Wang H; Jiang S; Zhang Y; Pan K; Xia J; Chen M
World J Surg Oncol; 2014 Jul; 12():226. PubMed ID: 25037578
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of ARK5 is associated with poor prognosis in hepatocellular carcinoma.
Cui J; Yu Y; Lu GF; Liu C; Liu X; Xu YX; Zheng PY
Tumour Biol; 2013 Jun; 34(3):1913-8. PubMed ID: 23516026
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of BMP7 as an oncogene in hepatocellular carcinoma.
Li W; Cai HX; Ge XM; Li K; Xu WD; Shi WH
Tumour Biol; 2013 Apr; 34(2):669-74. PubMed ID: 23179403
[TBL] [Abstract][Full Text] [Related]
8. High Expression of Neuropilin-1 Associates with Unfavorable Clinicopathological Features in Hepatocellular Carcinoma.
Zhang Y; Liu P; Jiang Y; Dou X; Yan J; Ma C; Fan Q; Wang W; Su F; Tang H; Su X
Pathol Oncol Res; 2016 Apr; 22(2):367-75. PubMed ID: 26563279
[TBL] [Abstract][Full Text] [Related]
9. Expression of cytoskeleton regulatory protein Mena in human hepatocellular carcinoma and its prognostic significance.
Hu K; Wang J; Yao Z; Liu B; Lin Y; Liu L; Xu L
Med Oncol; 2014 May; 31(5):939. PubMed ID: 24683008
[TBL] [Abstract][Full Text] [Related]
10. Suppression of SAMSN1 Expression is Associated with the Malignant Phenotype of Hepatocellular Carcinoma.
Sueoka S; Kanda M; Sugimoto H; Shimizu D; Nomoto S; Oya H; Takami H; Ezaka K; Hashimoto R; Tanaka Y; Okamura Y; Yamada S; Fujii T; Nakayama G; Koike M; Fujiwara M; Kodera Y
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1453-60. PubMed ID: 25805236
[TBL] [Abstract][Full Text] [Related]
11. Prostate tumor overexpressed 1 is a novel prognostic marker for hepatocellular carcinoma progression and overall patient survival.
Chen SP; Zhang LS; Fu BS; Zeng XC; Yi HM; Jiang N
Medicine (Baltimore); 2015 Jan; 94(4):e423. PubMed ID: 25634174
[TBL] [Abstract][Full Text] [Related]
12. NKD1 correlates with a poor prognosis and inhibits cell proliferation by inducing p53 expression in hepatocellular carcinoma.
Zhang S; Li J; Wang X
Tumour Biol; 2016 Oct; 37(10):14059-14067. PubMed ID: 27507614
[TBL] [Abstract][Full Text] [Related]
13. IMP3 combined with CD44s, a novel predictor for prognosis of patients with hepatocellular carcinoma.
Hu S; Wu X; Zhou B; Xu Z; Qin J; Lu H; Lv L; Gao Y; Deng L; Yin J; Li G
J Cancer Res Clin Oncol; 2014 Jun; 140(6):883-93. PubMed ID: 24647926
[TBL] [Abstract][Full Text] [Related]
14. Extracellular HSP70-peptide complexes promote the proliferation of hepatocellular carcinoma cells via TLR2/4/JNK1/2MAPK pathway.
Zhe Y; Li Y; Liu D; Su DM; Liu JG; Li HY
Tumour Biol; 2016 Oct; 37(10):13951-13959. PubMed ID: 27492456
[TBL] [Abstract][Full Text] [Related]
15. Effects of miR-152 on cell growth inhibition, motility suppression and apoptosis induction in hepatocellular carcinoma cells.
Dang YW; Zeng J; He RQ; Rong MH; Luo DZ; Chen G
Asian Pac J Cancer Prev; 2014; 15(12):4969-76. PubMed ID: 24998573
[TBL] [Abstract][Full Text] [Related]
16. Low CDX1 expression predicts a poor prognosis for hepatocellular carcinoma patients after hepatectomy.
Zheng H; Yang Y; Wang MC; Yuan SX; Tian T; Han J; Ni JS; Wang J; Xing H; Zhou WP
Surg Oncol; 2016 Sep; 25(3):171-7. PubMed ID: 27566019
[TBL] [Abstract][Full Text] [Related]
17. Roles of fibroblast growth factor-inducible 14 in hepatocellular carcinoma.
Li N; Hu WJ; Shi J; Xue J; Guo WX; Zhang Y; Guan DX; Liu SP; Cheng YQ; Wu MC; Xie D; Liu SR; Cheng SQ
Asian Pac J Cancer Prev; 2013; 14(6):3509-14. PubMed ID: 23886137
[TBL] [Abstract][Full Text] [Related]
18. Low levels of glycoprotein 96 indicate a worse prognosis in early-stage hepatocellular carcinoma patients after hepatectomy.
Ji F; Zhang Y; Zhu ZB; Guo Y; Shen SL; Cao QH; Li SQ; Peng BG; Liang LJ; Hua YP
Hum Pathol; 2019 Apr; 86():193-202. PubMed ID: 30529751
[TBL] [Abstract][Full Text] [Related]
19. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
20. Chromobox homolog 4 is correlated with prognosis and tumor cell growth in hepatocellular carcinoma.
Wang B; Tang J; Liao D; Wang G; Zhang M; Sang Y; Cao J; Wu Y; Zhang R; Li S; Ding W; Zhang G; Kang T
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S684-92. PubMed ID: 23943028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
